Theofilos Charles Steve 13D and 13G filings for Akari Therapeutics, Plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-06-18 4:15 pm Purchase |
2024-05-31 | 13D | Akari Therapeutics, Plc AKTX |
Theofilos Charles Steve | 2,370,750,000 9.990% |
2,370,750,000 (New Position) |
Filing |